--- title: "Zivo Bioscience (ZIVO) news: delisting" url: "https://aibio.space/companies/zivo-bioscience/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ZIVO delisting news: ZIVO Bioscience to delist from OTC markets and file Form 15 to end SEC reporting. Zivo Bioscience, Inc. (OTC: ZIVO), United States." --- ZIVO Zivo Bioscience, Inc. OTC · United States # Zivo Bioscience (ZIVO) news ZIVO delisting news Listings · 2026-03-30 ## [ZIVO Bioscience to delist from OTC markets and file Form 15 to end SEC reporting](https://aibio.space/news/zivo-bioscience-delist-otc-markets-file-form-15-end-sec-reporting/) The board says SEC reporting costs are no longer in the best interests of the company and its stockholders. ZIVO plans to file the form on or around March 30, 2026. ## Latest Zivo Bioscience news We have not published a story on Zivo Bioscience yet. When there is news, it will appear here. ## Zivo Bioscience at a glance - **Ticker**: ZIVO - **Listing**: OTC - **Country**: United States - **Cash, Sep 30, 2025**: $57,222 ### Related companies - [SQZ Biotechnologies](https://aibio.space/companies/sqz-biotechnologies/) OTC: SQZB - [Contineum Therapeutics](https://aibio.space/companies/contineum-therapeutics/) NASDAQ: CTNM - [Solid Biosciences](https://aibio.space/companies/solid-biosciences/) NASDAQ: SLDB - [Decoy Therapeutics](https://aibio.space/companies/decoy-therapeutics/) NASDAQ: DCOY - [Shattuck Labs](https://aibio.space/companies/shattuck-labs/) NASDAQ: STTK - [Vistagen Therapeutics](https://aibio.space/companies/vistagen-therapeutics/) NASDAQ: VTGN - [Entrada Therapeutics](https://aibio.space/companies/entrada-therapeutics/) NASDAQ: TRDA - [Denali Therapeutics](https://aibio.space/companies/denali-therapeutics/) NASDAQ: DNLI ### Also on OTC - [PyroGenesis Canada](https://aibio.space/companies/pyrogenesis-canada/) PYRGF - [Procaps Group](https://aibio.space/companies/procaps-s-a/) PROCF - [Lifeloc Technologies](https://aibio.space/companies/lifeloc-technologies/) LCTC - [Herborium Group](https://aibio.space/companies/herborium/) HBRM - [ENDONOVO THERAPEUTICS, INC.](https://aibio.space/companies/endonovo-therapeutics/) ENDV - [PROCYON CORP](https://aibio.space/companies/procyon/) PCYN ## What Zivo Bioscience does Zivo Bioscience, Inc. is a research and development company operating in both the biotech and agtech sectors. Its intellectual property portfolio includes proprietary algal and bacterial strains, biologically active molecules, and production and cultivation techniques for human and animal health. Its therapeutic strategy develops bioactive extracts and molecules from its proprietary algal culture for diseases such as poultry coccidiosis, bovine mastitis, human cholesterol and canine osteoarthritis. Its lead candidate targets coccidiosis in broiler chickens and is described as a non-antibiotic immune modulator. In its nutrition business, the company sells a dried green algae powder with over 50% protein, produced at a site in Peru operated with Grupo Alimenta. Under a contract manufacturing arrangement, the company's ZIVOLife subsidiary commits to purchasing the entire output. Commercial shipments for human consumption began in June 2023 through a global distribution agreement. Full capacity at the Peru site is planned for 2027, with capability to produce roughly 100,000 kg per year. | Product or program | What it is | Stage | |---|---|---| | Coccidiosis product candidate | Non-antibiotic immune modulator for coccidiosis in broiler chickens | | | Dried green algae powder | Algae powder with over 50% protein for food or food ingredient use | Commercial shipments began June 2023 | Summarised from the company's [10-K filed Mar 18, 2025](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/zivo_10k.htm). ## Zivo Bioscience annual financials | Line | FY2024 | FY2023 | |---|---|---| | Revenue | [$157,220](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/) | [$27,650](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/) | | Research and development | [$3.1 million](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/) | [$1.4 million](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/) | | Net income (loss) | [-$13.4 million](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/) | [-$7.8 million](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/) | | Cash from operations | [-$4.3 million](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/) | [-$5.8 million](https://www.sec.gov/Archives/edgar/data/1101026/000165495425002948/) | | Cash and equivalents | [$1.5 million](https://www.sec.gov/Archives/edgar/data/1101026/000165495425013095/) | [$274,380](https://www.sec.gov/Archives/edgar/data/1101026/000165495425013095/) | Latest balance sheet, Sep 30, 2025 (10-Q): cash and equivalents $57,222. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Zivo Bioscience Was Zivo Bioscience delisted? Our latest story on this, dated Mar 30, 2026: "ZIVO Bioscience to delist from OTC markets and file Form 15 to end SEC reporting". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/zivo-bioscience-delist-otc-markets-file-form-15-end-sec-reporting/). What is the ticker symbol of Zivo Bioscience? Zivo Bioscience, Inc. trades under the ticker ZIVO on OTC. Where is Zivo Bioscience listed? Zivo Bioscience, Inc. is listed on OTC. What is the SEC CIK of Zivo Bioscience? The SEC Central Index Key (CIK) for Zivo Bioscience, Inc. is 1101026. Its filings are on SEC EDGAR. How many shares does Zivo Bioscience have outstanding? 3,888,595 shares as of 2025-11-09, per the cover page of its 10-Q filed 2025-11-14. Which country or territory is Zivo Bioscience listed under? Our directory records Zivo Bioscience, Inc. under United States. What does Zivo Bioscience do? Our directory classifies Zivo Bioscience, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Zivo Bioscience? The ISIN recorded for Zivo Bioscience, Inc. is US98978N3098. Does aibio.space cover Zivo Bioscience? aibio.space lists Zivo Bioscience, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Zivo Bioscience incorporated? SEC records list its state or country of incorporation as NV. What does Zivo Bioscience develop? Zivo Bioscience, Inc. is a research and development company operating in both the biotech and agtech sectors. Its intellectual property portfolio includes proprietary algal and bacterial strains, biologically active molecules, and production and cultivation techniques for human and animal health. What is Coccidiosis product candidate from Zivo Bioscience? Coccidiosis product candidate: Non-antibiotic immune modulator for coccidiosis in broiler chickens Stage: Stage not stated. What is Dried green algae powder from Zivo Bioscience? Dried green algae powder: Algae powder with over 50% protein for food or food ingredient use Stage: Commercial shipments began June 2023. What was Zivo Bioscience's revenue last year? $157,220 for the fiscal year ended Dec 31, 2024, as reported to the SEC. Is Zivo Bioscience profitable? Zivo Bioscience, Inc. reported a net loss of $13.4 million for the fiscal year ended Dec 31, 2024, and used $4.3 million of cash in operations, per its annual report to the SEC. ## Investor discussion: Zivo Bioscience Members talk about Zivo Bioscience (ZIVO). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Zivo Bioscience, newest first. Each line links the filing it comes from. 1. 2026-03-31 Listings Filed to end its SEC reporting. SEC Form 15-12G. [Source](https://www.sec.gov/Archives/edgar/data/1101026/000165495426002990/zivo_1512g.htm) 2. 2026-03-30 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 5.02,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1101026/000165495426002928/zivo_ex991.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:ZIVO on TradingView](https://www.tradingview.com/symbols/OTC-ZIVO/). ## SEC filings and registration - **SEC name**: Zivo Bioscience, Inc. - **CIK**: 1101026 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: ZIVO (OTC) - **State or country of incorporation**: NV - **Fiscal year ends**: December 31 - **Filer category**: Non-accelerated filer
Smaller reporting company - **Business address**: 21 E. LONG LAKE ROAD, BLOOMFIELD HILLS, MI, 48304 - **Phone**: (248) 452 9866 - **Shares outstanding**: 3,888,595 as of 2025-11-09 (10-Q filed 2025-11-14) - **Former names**: HEALTH ENHANCEMENT PRODUCTS INC; WESTERN GLORY HOLE INC ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1101026/000165495426002928/zivo_8k.htm) filed 2026-03-30 - [8-K](https://www.sec.gov/Archives/edgar/data/1101026/000165495425014296/zivo_8k.htm) filed 2025-12-23 - [10-Q](https://www.sec.gov/Archives/edgar/data/1101026/000165495425013095/zivo_10q.htm) filed 2025-11-14 - [8-K](https://www.sec.gov/Archives/edgar/data/1101026/000165495425010579/zivo_8k.htm) filed 2025-09-10 - [8-K](https://www.sec.gov/Archives/edgar/data/1101026/000165495425009772/zivo_8k.htm) filed 2025-08-18 - [10-Q](https://www.sec.gov/Archives/edgar/data/1101026/000165495425009650/zivo_10q.htm) filed 2025-08-14 - [8-K](https://www.sec.gov/Archives/edgar/data/1101026/000165495425008035/zivo_8k.htm) filed 2025-07-14 - [8-K](https://www.sec.gov/Archives/edgar/data/1101026/000165495425006837/zivo_8k.htm) filed 2025-06-11 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001101026), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Zivo Bioscience, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker ZIVO, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Zivo Bioscience, Inc. - **Ticker**: ZIVO - **Listing**: OTC - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: US98978N3098 - **Last quote in directory**: 2026-10-19 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/OTC-ZIVO/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/zivo-bioscience/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Zivo Bioscience (ZIVO) news: delisting", 2026-10-31, https://aibio.space/companies/zivo-bioscience/